Adaptive Neuro-Fuzzy Inference System (ANFIS) Applied for Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid Determination of fluoxetine and sertraline in pharmaceutical formulations and biological fluid
Iranian Journal of Pharmaceutical Sciences,
Vol. 10 No. 3 (2014),
1 July 2014
,
Page 19-34
https://doi.org/10.22037/ijps.v10.40812
Abstract
https://doi.org/10.22034/IJPS.2014.15251
The UV-spectrophotometric method of analysis was proposed for simultaneous determination of fluoxetine (FLX) and sertraline (SRT). Considering the strong spectral overlap between UV-Vis spectra of these compounds, a previous separation should be carried out in order to determine them by conventional spectrophotometric techniques. Here, full-spectrum multivariate calibrations adaptive neuro-fuzzy inference system (ANFIS) method is developed.Adaptive neuro-fuzzyinference system (ANFIS) is a neuro fuzzy technique where the fusion is made between the neural network and the fuzzy inference system that is a computational method. The experimental calibration matrix was constructed with 30 samples. The concentration ranges considered were 5-120μg.mL−1fluoxetine and 10-120μg.mL−1sertraline .Absorbance data of the calibration standards were taken between 200-300nm with UV-Vis spectrophotometer. The method was applied to accurately and simultaneously determine the content of pharmaceutical in several synthetic mixtures and real samples. Assaying various synthetic mixtures of the components validated the presented methods. Mean recovery values were found to be 101.26% and 100.24%, respectively for determination of FLX and SRT.
Keywords:
- Adaptive neuro-fuzzy inference system (ANFIS)
- Biological fluids
- Fuzzy logic
- Fluoxetine
- Sertraline
- Spectrophotometric
How to Cite
Hamid Reza Akbari Hasanjani, Mahmoud Reza Sohrabi, & Parviz Abdolmaleki. (2014). Adaptive Neuro-Fuzzy Inference System (ANFIS) Applied for Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid: Determination of fluoxetine and sertraline in pharmaceutical formulations and biological fluid. Iranian Journal of Pharmaceutical Sciences, 10(3), 19–34. https://doi.org/10.22037/ijps.v10.40812
References
[1] AudriusSveikata, Vita Danileviciute. Comtemporary approach to pharmacological and clinical aspects of novalantidepressatnts.Medicina.(2002)38 (12): 1147-1156.
[2] Lopcz AD, Murray CJ; The global burden of diseases. acomperativeassesements of mortality and disabililty from diseases, injuries and risk factor in 1990-2020 and projected to 2020. Bostan, MA.Harvard university press.(1996)
[3] WHO. World health organization, (2005).Statistical data for depression.
[4] Moffat, Anthony C; Osselton, M David; Widdop, Brian; Watts, Jo. Clarke’s analysis of drugs and poisons. London: Pharmaceutical Press.(2004)
[5] http://medicine complete.com// Fluoxetine Clark’s analysis of drug and poison.htm
[6] Murdoch D, McTavish D. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs.(1992) 44:604–624.
[7] J.F. Nash, R.J. Bopp, R.H. Carmichael, K.Z. Farid, L. Lemberger. Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection.Clin. Chem. (1982) 28 :2100.
[8] Emad M. Hussien, Nahla S. Ismail and Fatma M. Abdel-Gawad, Potentiometric carbon paste ISEs for determination of fluoxetine hydrochloride in pharmaceutical preparations , International Journal of Current Pharmaceutical Research,(2013)5:18-22.
[9] J.G. Flood, P.R. Puopolo, Detection of interference by cyclobenzaprine in liquid-chromatographic assays of tricyclic antidepressants.Clin. Chem. (1987)33(6):819-20.
[10] P. Thomare, K. Wang, V. van der Meerch-Mougeot, B. Diquet, ,Sensitive micro-method for column liquid chromatographic determination of fluoxetine and norfluoxetine in human plasma J. Chromatogr. (1992)583:217.
[11] A. El-Yazigi, D.A. Ruines, Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, nortriptyline, and desipramine in plasma.Ther. Drug Monit.(1993) 15(4):305-9.
[12] J.H. Nichols, J.R. Charlson, G.M. Lawson, ,Automated HPLC assay of fluoxetine and norfluoxetine in serum.Clin. Chem. (1994) 40(7 Pt 1):1312-6.
[13] D.D. Writh, B.A. Olsen, D.K. Hallenbeck, M.G. Lake, S.M. Gregg, F.M. Perry, Screening Methods for Impurities in Multi-sourced Fluoxetine Hydrochloride Drug Substances and Formulations. Chromatographia,(1997) 46: 511-23.
[14] G. Aymard, P. Livi, Y.T. Pham, B. Diquet, Sensitive and rapid method for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection,J. Chromatogr. Biomed.Appl. ,(1997)700:183-189.
[15] V. Dixit, H. Nguyen, V.M. Dixit, Solid-phase extraction of fluoxetine and norfluoxetine from serum with gas chromatography-electron-capture detection. J. Chromatogr. Biomed.(1991)563(2):379-84
[16] G.A. Torok-Both, G.B. Baker, R.T. Coutts, K.F. Mckenna, L.J. Aspeslet, Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J. Chromatogr. Biomed.(1992)579(1):99-106.
[17] R.T. Sane, A.B. Jani, J.K. Ghodge, A.J. Vaidya, S.S. Kotwal, Comparative evaluation of pharmacokinetic and bioequivalence study of omeprazole capsules in healthyIndian men. Indian Drugs (1992)29: 445-6.
[18] S. Raghuveer, A.B. Avadhanulu, A.R.R. Pantulu, Indian Drugs (1993) 30: 83.
[19] B. Levine, A.J. Jenkins, J.E. Smialek, Distribution of sertraline in postmortem cases, J. Anal. Toxicol.(1994)18(5):272-4.
[20] D. Rogowsky, M. Marr, G. Long, C. Moore, Determination of sertraline and desmethylsertraline in human serum using copolymeric bonded-phase extraction, liquid chromatography and gas chromatography-mass spectrometry. J. Chromatogr. Biomed.(1994)655(1):138-41.
[21] B.K. Logan, P.N. Friel, G.A. Case, Analysis of sertraline (Zoloft) and its major metabolite in postmortem specimens by gas and liquid chromatography. J. Anal. Toxicol.(1994)18:139-42.
[22] Fouda HG, Ronfeld RA, Weidler DJ, Gas-chromatographic - mass-spectrometric analysis and preliminary human pharmacokinetics of sertraline, a new antidepressant drug. J.Chromatogr Biomed Appl,(1987)61:197-202.
[23] L.M. Tremaine, E.A. Joerg, Automated gas chromatographic-electron-capture assay for the selective serotonin uptake blocker sertraline, J. Chromatogr. Biomed.(1989) 496:423–429
[24] R.N. Gupta, S.A. Dziurdzy, Therapeutic monitoring of sertraline.Clin. Chem. (1994) 40:498-9.
[25] M. I. Walash, F. Belal, N. El-Enany, and H. El-Mansi, Spectrophotometric Determination of the Antidepressants Sertraline and Paroxetine HCl using 2,4-Dinitrofluorobenzene, Biomed Sci.(2010) 6(3): 252–259.
[26] J. Patel, E.P. Spencer, R.J. FlanganHPLC of sertraline and norsertraline in plasma or serum.Biomed.Chromatogr.(1996)6:351-354.
[27] T.C. O’Haver, G.L. Green, Numerical error analysis of derivative spectrometry for the quantitative analysis of mixtures, Anal. Chem. (1976) 48 (2), 312–318.
[28] M. Blanco, J. Coello, F. González, H. Iturriaga, S. Maspoch, Simultaneous determination of metal ions.Catalytic oxidation of cobalt by metal ions when extracted with quinolin-8-ol Anal.Chim.Acta, (1990)
230: 221–224.
[29] P. Geladi, B.R. Kowalski, Partial Least Squares Regression, Anal. Chim.Acta(1986)185: 1-17.
[30] T. R. Cundari and M. Russo, “Database mining using soft computing techniques. an integral neural network-fuzzy logic-genetic algorithm approach,” J. Chem. Inf. Sci.(2001) 41: 281–287
[31] L.A. Zadeh, Fuzzy setsInf. Contr.(1965) 8:338–353.
[32] M. Sugeno, G. Kang, Fuzzy Set Syst.(1988):28, 15.
[33]Rahul Malhotra, Narinder Singh, Yaduvir Singh. Fuzzy Logic Modelling, Simulation and Control: A Review, International Journal of Computer Science and Technology,(2010)1:183-188
[34] Jang JSR. ANFIS – adaptive-network-based fuzzy inference system. IEEE Trans Syst Man Cybern,(1993)23:665–85.
[35] Castillo O, Melin P. Soft computing for control of nonlinear dynamical system. Heidelberg, New York: Physica-Verlag; 2001.
[36] M.A. Cantarelli, R.G. Pellerano, E.J. Marchevsky, J.M. Camina, Simultaneous determination of amoxicillin and diclofenac in pharmaceutical formulations using UV spectral data and the PLS chemometric method.Anal Sci.(2011) 27(1):73-8.
[2] Lopcz AD, Murray CJ; The global burden of diseases. acomperativeassesements of mortality and disabililty from diseases, injuries and risk factor in 1990-2020 and projected to 2020. Bostan, MA.Harvard university press.(1996)
[3] WHO. World health organization, (2005).Statistical data for depression.
[4] Moffat, Anthony C; Osselton, M David; Widdop, Brian; Watts, Jo. Clarke’s analysis of drugs and poisons. London: Pharmaceutical Press.(2004)
[5] http://medicine complete.com// Fluoxetine Clark’s analysis of drug and poison.htm
[6] Murdoch D, McTavish D. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs.(1992) 44:604–624.
[7] J.F. Nash, R.J. Bopp, R.H. Carmichael, K.Z. Farid, L. Lemberger. Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection.Clin. Chem. (1982) 28 :2100.
[8] Emad M. Hussien, Nahla S. Ismail and Fatma M. Abdel-Gawad, Potentiometric carbon paste ISEs for determination of fluoxetine hydrochloride in pharmaceutical preparations , International Journal of Current Pharmaceutical Research,(2013)5:18-22.
[9] J.G. Flood, P.R. Puopolo, Detection of interference by cyclobenzaprine in liquid-chromatographic assays of tricyclic antidepressants.Clin. Chem. (1987)33(6):819-20.
[10] P. Thomare, K. Wang, V. van der Meerch-Mougeot, B. Diquet, ,Sensitive micro-method for column liquid chromatographic determination of fluoxetine and norfluoxetine in human plasma J. Chromatogr. (1992)583:217.
[11] A. El-Yazigi, D.A. Ruines, Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, nortriptyline, and desipramine in plasma.Ther. Drug Monit.(1993) 15(4):305-9.
[12] J.H. Nichols, J.R. Charlson, G.M. Lawson, ,Automated HPLC assay of fluoxetine and norfluoxetine in serum.Clin. Chem. (1994) 40(7 Pt 1):1312-6.
[13] D.D. Writh, B.A. Olsen, D.K. Hallenbeck, M.G. Lake, S.M. Gregg, F.M. Perry, Screening Methods for Impurities in Multi-sourced Fluoxetine Hydrochloride Drug Substances and Formulations. Chromatographia,(1997) 46: 511-23.
[14] G. Aymard, P. Livi, Y.T. Pham, B. Diquet, Sensitive and rapid method for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection,J. Chromatogr. Biomed.Appl. ,(1997)700:183-189.
[15] V. Dixit, H. Nguyen, V.M. Dixit, Solid-phase extraction of fluoxetine and norfluoxetine from serum with gas chromatography-electron-capture detection. J. Chromatogr. Biomed.(1991)563(2):379-84
[16] G.A. Torok-Both, G.B. Baker, R.T. Coutts, K.F. Mckenna, L.J. Aspeslet, Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J. Chromatogr. Biomed.(1992)579(1):99-106.
[17] R.T. Sane, A.B. Jani, J.K. Ghodge, A.J. Vaidya, S.S. Kotwal, Comparative evaluation of pharmacokinetic and bioequivalence study of omeprazole capsules in healthyIndian men. Indian Drugs (1992)29: 445-6.
[18] S. Raghuveer, A.B. Avadhanulu, A.R.R. Pantulu, Indian Drugs (1993) 30: 83.
[19] B. Levine, A.J. Jenkins, J.E. Smialek, Distribution of sertraline in postmortem cases, J. Anal. Toxicol.(1994)18(5):272-4.
[20] D. Rogowsky, M. Marr, G. Long, C. Moore, Determination of sertraline and desmethylsertraline in human serum using copolymeric bonded-phase extraction, liquid chromatography and gas chromatography-mass spectrometry. J. Chromatogr. Biomed.(1994)655(1):138-41.
[21] B.K. Logan, P.N. Friel, G.A. Case, Analysis of sertraline (Zoloft) and its major metabolite in postmortem specimens by gas and liquid chromatography. J. Anal. Toxicol.(1994)18:139-42.
[22] Fouda HG, Ronfeld RA, Weidler DJ, Gas-chromatographic - mass-spectrometric analysis and preliminary human pharmacokinetics of sertraline, a new antidepressant drug. J.Chromatogr Biomed Appl,(1987)61:197-202.
[23] L.M. Tremaine, E.A. Joerg, Automated gas chromatographic-electron-capture assay for the selective serotonin uptake blocker sertraline, J. Chromatogr. Biomed.(1989) 496:423–429
[24] R.N. Gupta, S.A. Dziurdzy, Therapeutic monitoring of sertraline.Clin. Chem. (1994) 40:498-9.
[25] M. I. Walash, F. Belal, N. El-Enany, and H. El-Mansi, Spectrophotometric Determination of the Antidepressants Sertraline and Paroxetine HCl using 2,4-Dinitrofluorobenzene, Biomed Sci.(2010) 6(3): 252–259.
[26] J. Patel, E.P. Spencer, R.J. FlanganHPLC of sertraline and norsertraline in plasma or serum.Biomed.Chromatogr.(1996)6:351-354.
[27] T.C. O’Haver, G.L. Green, Numerical error analysis of derivative spectrometry for the quantitative analysis of mixtures, Anal. Chem. (1976) 48 (2), 312–318.
[28] M. Blanco, J. Coello, F. González, H. Iturriaga, S. Maspoch, Simultaneous determination of metal ions.Catalytic oxidation of cobalt by metal ions when extracted with quinolin-8-ol Anal.Chim.Acta, (1990)
230: 221–224.
[29] P. Geladi, B.R. Kowalski, Partial Least Squares Regression, Anal. Chim.Acta(1986)185: 1-17.
[30] T. R. Cundari and M. Russo, “Database mining using soft computing techniques. an integral neural network-fuzzy logic-genetic algorithm approach,” J. Chem. Inf. Sci.(2001) 41: 281–287
[31] L.A. Zadeh, Fuzzy setsInf. Contr.(1965) 8:338–353.
[32] M. Sugeno, G. Kang, Fuzzy Set Syst.(1988):28, 15.
[33]Rahul Malhotra, Narinder Singh, Yaduvir Singh. Fuzzy Logic Modelling, Simulation and Control: A Review, International Journal of Computer Science and Technology,(2010)1:183-188
[34] Jang JSR. ANFIS – adaptive-network-based fuzzy inference system. IEEE Trans Syst Man Cybern,(1993)23:665–85.
[35] Castillo O, Melin P. Soft computing for control of nonlinear dynamical system. Heidelberg, New York: Physica-Verlag; 2001.
[36] M.A. Cantarelli, R.G. Pellerano, E.J. Marchevsky, J.M. Camina, Simultaneous determination of amoxicillin and diclofenac in pharmaceutical formulations using UV spectral data and the PLS chemometric method.Anal Sci.(2011) 27(1):73-8.
- Abstract Viewed: 251 times
- IJPS_Volume 10_Issue 3_Pages 19-34 Downloaded: 258 times